Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
56.99%
Threshold
Crossed downwards
Timeline
Published
26.03.2021
Transaction
19.03.2021
Voting rights breakdown
Voting rights acquired0.56%
Voting rights sold56.99%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAL3O00038
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
regarding certain sales positions
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open